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Wireless Capsule Endoscope for Targeted Drug
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Abstract—This paper describes a platform to achieve targeted
drug delivery in next generation wireless capsule endoscopy.
The platform consists of two highly novel sub-systems: one is a
micro-positioning mechanism which can deliver 1 ml of targeted
medication and the other is a holding mechanism which gives
the functionality of resisting peristalsis. The micro-positioning
mechanism allows a needle to be positioned within a 22.5o
segment of a cylindrical capsule and be extendible by up to
1.5 mm outside the capsule body. The mechanism achieves both
these functions using only a single micro-motor and occupying
a total volume of just 200 mm3. The holding mechanism can be
deployed diametrically opposite the needle in 1.8 s and occupies
a volume of just 270 mm3. An in-depth analysis of the mechanics
is presented and an overview of the requirements necessary to
realise a total system integration is discussed. It is envisaged that
the targeted drug delivery platform will empower a new breed
of capsule micro-robots for therapy in addition to diagnostics for
pathologies such as ulcerative colitis and small intestinal Crohn’s
disease.
Index Terms—wireless capsule endoscopy, gastrointestinal (GI)
tract, targeted therapy, micro-robot, pill robot.
I. INTRODUCTION
THERE are a number of wireless capsule endoscopes(WCE) available for detecting and diagnosing patholo-
gies of the gastrointestinal (GI) tract such as small intestinal
Crohn’s disease, obscure gastrointestinal bleeding (OGIB) and
small intestinal tumours.
One such capsule is the M2A developed by Given Imaging
Ltd. [1] in 2000. This system was developed specifically for
examining the small intestines as conventional endoscopes
cannot reach the total length of the GI tract [2]. Its small size of
11.0 mm in diameter × 25.0 mm long allows it to pass through
the GI tract under natural peristalsis pressure. Another similar
system is the EndoCapsule by Olympus [3]. These systems use
onboard CMOS or CCD-based image sensors to take pictures
of the intestinal wall. The pictures can be transmitted to a
device worn by the patient for later evaluation. A detailed
review of WCE is reported in [4].
Current WCE systems in general do not have the function-
ality or the onboard capacity to treat pathologies of the GI
tract, such as ulcerative colitis, with medication as they are
limited to diagnostic use. However there is a clinical need to
target and treat these pathologies [5] hence endeavours have
been made by researchers such as Philips Electronics with
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Fig. 1. Micro-robot concept design capable of resisting peristaltic pressure
through an integrated holding mechanism and delivering 1 ml targeted medica-
tion. Holding mechanism shown partially open and the needle fully extended
to 1.5 mm outside the capsule body
IntelliCap [6], Innovative Devices LLC with the InteliSite
[7] and Phaeton Research with the Enterion capsule [8] to
perform regional drug absorption services. These systems are
capable of delivering up to 1 ml of medication to a region
of the GI tract such as the jejunum, ileum, ascending colon
or descending colon either through the progressive release of
medication over a period of time or through a bolus form.
The delivery methods employed by these devices prevents
the direct targeting of specific pathogens such as tumours or
ulcers as the medication is spread over a section of lumen due
to the constant movement from peristalsis, further they have
no means of stopping and holding their position.
This paper presents a platform for delivering a targeted dose
of medication in a confined compliant tubular environment.
The platform comprises a holding mechanism and a needle
positioning mechanism which are integrated into a WCE. This
integration gives increased functionality allowing the WCE to
be used for targeted drug delivery in the GI tract. Specifically
this paper focuses on the two key mechanisms and is organised
as follows: Section II introduces the concept and requirements,
Section III describes the holding mechanism for resisting
peristalsis, Section IV describes the targeting/delivery mecha-
nism, Section V discusses additional platform considerations
required to complete a system realisation, and Section VI
concludes this work.
II. CONCEPT AND DESIGN REQUIREMENTS
Conventional WCE have sufficiently small geometry to
allow them to pass through the small intestines and navigate
the ileocolic valve without becoming an obstruction. However
the clinical need to target a specific location or feature within
the GI tract for medication delivery or examination of the
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intestinal wall would require the WCE to stop. Fig. 1 shows
a micro-robot concept design capable of resisting peristaltic
pressure through the deployment of an integrated holding
mechanism and targeted drug delivery through the activation
of a needle. The needle has the ability to be positioned in a 360
degree envelope. Simultaneously the holding mechanism can
stay diametrically opposite the needle guaranteeing penetration
of the GI tract wall.
A. Movement Analysis of the GI Tract
Once swallowed the WCE will pass through the elementary
canal. The particular section of interest for diagnosis and
treatment is the small intestines as this section is very difficult
to access. The small intestines comprise of the duodenum,
the jejunum and the ileum. These three sections make up
the longest part of the alimentary canal at 6.25 m [9]. The
duodenum is C shaped and its mouth, the ileocolic valve,
extends from the stomach giving this section a degree of
stability. The jejunum and the ileum are free to move however
their natural state is collapsed.
In order to process foodstuff, a liquid mixture called chyme,
the small intestines uses a series of movement patterns. These
patterns, segmentation and peristalsis [10], cause the chyme
to progress through the tract. Segmentation is a contraction
of the duodenum for the purpose of mixing food. There
are two processes involved, they are eccentric contractions
and concentric contraction. The first generates very little
intraluminal pressure and the second can generate pressures
as high as 20 mmHg [10]. The frequency of the contractions
is dependent on eating patterns, becoming stronger as chyme
is being processed. Peristalsis is the process of moving chyme
through the intestinal tract from the stomach to the colon
by means of a series of muscle contractions acting in a
wave pattern. The muscle contraction acts in two planes,
circumferential and longitudinal. Miftahof (2005) [11] has
developed a mathematical model to describe the dynamics
of the electromechanical wave phenomenon of a segment of
the gut. They report that the active force of contraction in
the longitudinal direction to have an amplitude of 26.9 g/cm
and an amplitude of 17.2 g/cm in the circumferential direc-
tion. For a conventional WCE with dimensions of 11.0 mm
diameter × 25.0 mm long, the circumferential and longitudinal
amplitudes translate into 421.8 mN and 911.9 mN respectively.
These estimated forces have been used as a guide in the design
analysis of the holding mechanism.
B. Resisting Peristalsis and Geometrical Constraints
There are three methods employed for halting the progress
of a WCE by enabling it to resist the natural movement from
peristalsis. One utilises micro-actuator mechanisms embedded
within the capsule, such as the paddling based microrobot
developed by Park et al. (2007) [12]. The second approach
exploits external magnetic fields to control the position of the
capsule and the third approach applies a stimulus to GI tract
to inhibit peristalsis [13].
There has been much development in the field of magnetic
control of WCE such as the magnetic shell employed by Carpi
et al. [14]. This system looks to modify existing WCE with the
addition of a magnetic shell. The shell can be used to guide
the WCE by means of an external magnetic field, however this
system requires large equipment to perform the procedure and
there is also an increase in the diameter of the WCE.
To overcome peristalsis a holding mechanism compact
enough to fit within the micro-robot yet leave sufficient space
for medication and other features is required. There have been
a number of systems employed by researchers to stop the
micro-robot, such as insufflation of the tract using balloons
or expanding legs [15]. However these systems exhibit limi-
tations. In the case of the expanding legs they are driven by a
leadscrew which is powered by a micro-motor. The leadscrew
and the micro-motor are axially aligned with the micro-robot.
This configuration requires a substantial amount of space and
presents problems of force translation through the legs due to
the lever effect.
C. Target Technical Specifications
The overall geometry of the micro-robotic system will be
greatly influenced by the limitations imposed by swallowing
and on its ability to navigate natural obstacles such as the
ileocolic valve without becoming an obstruction. A patient’s
ability to swallow a required volume will vary from person
to person, therefore a standard volume must be chosen which
will be suitable for the majority of patients. Research carried
out by Connor et al. (2009) shows that a volume of 3.0 cm3
can be swallowed [16]. This maximum target volume will be
required to house all the components necessary to perform
targeted therapy and micro-scale diagnosis. Table I lists the




Micro-robot volume maximum 3.0 cm3
Sensing pH, temp and pressure
Vision CMOS and optical dome
Illumination 4 white LEDs
Power source onboard battery
Tracking RF and time
Telemetry bidirectional
Attaining equilibrium holding
Delivering therapy liquid medication
Drug reservoir 1 ml
D. System Operation Overview
The main sequence of events required to perform a proce-
dure to deliver targeted therapy to the GI tract can be seen
in Fig 2. The procedure starts with the patient ingesting the
WCE. Once the capsule passes through the stomach and enters
the small intestines it can begin to transmit images to the
operator via an RF link. The real-time images and sensor
data will be displayed on an external PC. The operator will
use the data to identify an already defined target site. Once
the target site has been reached the operator will remotely
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Fig. 2. Flow diagram showing the key stages of operation for a procedure to deliver targeted therapy to the GI tract using a remotely operated WCE
deploy the holding mechanism. The operator can now rotate
the needle into any one of 16 predefined positions, the position
will be based on observational data received just before
the deployment of the holding mechanism. The needle can
now be advanced into the GI tract wall and the medication
released. The targeting mechanism is designed such that it
gives the operator the ability to reposition the needle before the
medication is delivered. Finally the capsule will be dispelled
through natural peristalsis movement.
III. HOLDING MECHANISM
The holding mechanism (Fig. 3a) uses a single micro-motor
to open and close two legs. The two legs are connected to a
central support via two pinned leg ties. The two-legged design
utilises a micro-motor which is orientated in a vertical position
(Fig. 4a). The micro-motor is connected to a bevel gear set,
this allows the micro-motor’s rotation to be translated through
90 degrees. The bevel gear drives a gear train of spur gears
which drive the legs in and out (Fig. 3b & 4b). This novel
configuration reduces the micro-motor’s RPM. The reduction
in RPM will result in a multiplication of the micro-motor’s
torque, this will give the legs the strength required to distend
the GI tract wall and hold the micro-robot in place.
To secure the micro-robot in place the holding mechanism
will be required to expand to a size which is sufficiently large
that it resists the natural movement from peristalsis. This is
achieved through an increase in circumference of the micro-
robot. The holding mechanism begins with a circumference
of 34.5 mm, however when activated the mechanism increases
in size to produce a circumference of 60.4 mm, which is an
increase of 75%. This can be further increased to 71.25 mm
by simply modifying the profile of the legs to increase the
surface area in contact with the GI tract wall.
The method by which the legs open and close poses the
potential risk of tissue becoming trapped in the mechanism,
however the orientation of the legs combined with their smooth
rounded ends will act to prevent the naturally collapsed GI
tract wall from penetrating the capsule’s leg cavity.
The advantage of the vertical configuration of the micro-
motor is that it allows for a very compact design (270mm3)
resulting in the most efficient use of space. The two legs,
central support, leg ties and the micro-robot case will absorb
the load from the GI tract wall. The compact gearing allows
the rate at which the legs are deployed to be controlled by the
ratio of the gear train.
Fig. 3. Holding mechanism concept which utilises a vertically orientated
micro-motor to give the WCE the ability to overcome peristalsis a) and a 3D
internal view of the gear train b)
Fig. 4. Holding mechanism design showing: a) 13 teeth and 48 teeth bevel
gears set, b) gear train and legs in the fully extended position. The central
spur gear is driven by the 48 teeth bevel gear.
A. Gear Train
For the holding mechanism to operate at a safe speed the
micro-motor will require the gear train to slow it down. The
chosen micro-motor is manufactured by Faulhaber and already
has an integral gearbox which reduces the 20,000 RPM by a
factor of 13:1. This results in a starting RPM of 1,538 RPM,
which is significantly high, therefore further reductions will
be achieved from the gear train. The output speed of a gear
train can be estimated from the following equation:
RPMout =
Nd1 ×Nd2 ×Nd3 ×Nd4 ×RPMin
Nf1 ×Nf2 ×Nf3 ×Nf4 (1)
Where RPMin is the input speed, Nd1 is the number of
teeth on the driving gear and Nf1 is the number of teeth on
the follower gear. This formula can be applied to the gear train
with a selection of gear teeth to determine the output RPM,
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Table II.
TABLE II
ESTIMATED GEAR TRAIN OUTPUT FROM AN INPUT OF 1,538 RPM
Gear stages Micromotor Bevel Second Output
and bevel gear and stage spur
gear spur gear spur gear gear
No. of teeth on driver (d) 13 8 8 8
No. of teeth on follower (f ) 48 34 34 22
Output RPM 417.93 98.34 23.14 8.41
As can be seen from Table II the number of teeth on the
follower gears is higher than the number of teeth on the
driving gears, this is to ensure a rapid reduction in RPM in
the minimum amount of space. The target is to deploy the
holding mechanism as slowly as possible as this will reduce
the potential for trauma to the GI tract wall from the legs and
supports. However there are limitations to the number of teeth
which can be used as the chosen gear module, which is the
ratio of the pitch diameter to the number of teeth on the gear,
determines the overall geometry of the gear. The chosen bevel
gear module is 0.2 this results in a maximum number of teeth
of 48 and an overall gear diameter of 10.0 mm (Fig. 4a) as
the gear has the overall limiting factor of the diameter of the
micro-robot. The spur gears use a module of 0.1 this results
in a maximum number of teeth of 34 as the gears are required
to be linked together in a train (Fig. 4b) they are therefore
limited again to the overall diameter of the micro-robot.
The gear train results in a reduction of 1,538 RPM to
8.4 RPM. This reduced output speed will deploy the legs in
approximately 1.8 seconds, altering the number of teeth on the
driver or follower will increase or decrease this figure.
An important function of the gear train is to transmit
power from the micro-motor to the legs, this will enable the
legs to distend the luminal wall and hold the micro-robot in
position. The power transmitting capacity of a gear train can
be determined by the following formula:
Tout =
Nf1 ×Nf2 ×Nf3 ×Nf4 × Tin
Nd1 ×Nd2 ×Nd3 ×Nd4 (2)
Where Tin is the input torque, Nf1 is the number of teeth
on the follower gear and Nd1 is the number of teeth on the
driving gear. Applying this formula to the gear train and using
0.15 mNm torque generated by the Faulhaber micro-motor as
the input torque (Tin) results in an estimated output torque
(Tout) of 27.5 mNm.
B. Analysis of Holding Mechanism Arms
To attain a state of equilibrium the external forces acting on
the micro-robot must be balanced for any given orientation,
however angles less than 90 degrees from the horizontal can be
neglected from the equilibrium analysis, as in the worst case
the load would be acting vertical to the horizontal resulting in a
multiplication factor of sin90 which equals 1 hence producing
no net increase in load. Fig. 5 shows the external forces acting
on the legs of the micro-robot. For the force analysis the
contact area has been divided into 6 contact points as these
Fig. 5. External radial peristaltic force (Pc) acting on the micro-robot at 6
positions
points will be in continuous contact with the GI tract wall
throughout the deployment of the mechanism.
As can be seen from Fig. 5 the external forces acting on
the micro-robot’s legs are the circumferential peristaltic force
(Pc), the linear peristaltic forces are neglected as they do not
contribute to the holding function and through FEA analysis
it has been shown that they are not sufficiently strong to cause
any deformation of the mechanism. Using the figures deter-
mined by Miftahof (2005) [11] the circumferential amplitude
of 26.9 g/cm results in an estimated load of 720.8 mN for the
total circumferential contact area of the extended legs and
micro-robot’s body.
The micromotor employed to drive the legs must be capable
of delivering an equivalent force to the legs to maintain a state
of equilibrium. The force acting at each point of contact (Pc)





Where Fc is the circumferential force from the GI tract wall
and mg is the weight of the micro-robot.
The load acting at each point equates to 120.1 mN, however
this load will work towards preventing the legs from opening.
C. Load Points (Pc) Contributing to Torque
The process of operating the legs from the stored position
to the fully extended position results in the circumferential
force from the GI tract wall (Pc) acting towards the centre of
the micro-robot. However only the perpendicular component
force (Fp1) will be working to prevent the legs from opening.
This is illustrated for leg 1 in Fig. 6.
The perpendicular component force Fp1 (Fig. 6) can be
estimated for a leg movement through zero degrees to 90




b2 + c2 − 2bc(cosA)
)
(4)
The perpendicular component force Fp2 acting on tie bar 1
can be seen in Fig. 7 and can be estimated as follows:
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Fig. 6. Component force (Fp1) of the radial peristaltic force (Pc) acting
on the micro-robot’s leg
Fig. 7. Component force (Fp2) of the radial peristaltic force (Pc) acting
on the micro-robot’s tie bar. The tie bar links the leg to the centre support























The radial peristaltic force (Pc) acting on the centre support
(Fig. 8) would be split between the two pivot points linking the
two tie bars, however the sum of the two points would count
towards the torque requirement. As the geometry and loading
are symmetrical only one side of the centre support requires












b3 − (b2 cosA3)
)]
(6)
Equation 6 uses the total peristaltic force (Pc) therefore the
resulting component force Fp3 represents the total component
force from both pivot points of the centre support.
Fig. 8. Component force (Fp3) of the radial peristaltic force (Pc) acting
on the micro-robot’s centre support
Fig. 9. Graph showing the individual perpendicular component forces
Fp1, Fp2, Fp3, Fp4 and Fp5 generated by the GI tract acting on the holding
mechanism and the total combined load Fp which will act to prevent the
holding mechanism from operating
The three individual perpendicular component forces
Fp1, Fp2 and Fp3 can be combined with Fp4 the perpendicular
component forces for tie bar 2 and Fp5 the perpendicular
component forces acting on leg 2 to find the maximum load
which will be delivered to the micro-motor through the zero to
90 degree leg movement. Fig. 9 shows a plot of the individual
loads through the full movement and the resulting combined
load (Fp).
The result of the combined plots (Fig. 9) shows the max-
imum load of 378.15 mN acting on the final gear in the
gear train to be at 90 degrees, this results in a torque of
2.78 mNm acting on the gear. However the estimated results of
equation 2 show an output torque (Tout) for the gear train to be
27.5 mNm this gives a high margin of safety before the micro-
motor stalls. The holding mechanism has been designed to
withstand the estimated force the GI tract wall can generate. A
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Fig. 10. Needle positioning mechanism assembly with material removed for
clarity. Needle shown in the fully retracted position
system validation including in-vivo measurements are required
to verify these results.
The 6 point loads have been used to confirm the stability of
the mechanism through FEA analysis. Using the FEA process
the thickness of the arms was optimised however the areas
that contact the GI tract wall may be increased in future trials
to limit any potential trauma to the GI tract wall.
IV. TARGETING AND DRUG DELIVERY MECHANISM
A. Needle Positioning Mechanism
A single micro-motor orientated along the axis of the micro-
robot’s body is used to drive the needle positioning mecha-
nism (Fig. 10). The needle positioning mechanism utilises a
1.5 mm diameter × 10.5 mm long micro-motor manufactured
by Namiki, a needle funnel, a movable needle, a needle
cam and two opposing ratchets. Also features integral to the
micro-robot’s body are required (protrusions). The sequence of
operation is to firstly position the needle angularly followed
by the extension of the needle and delivery of the medication,
then the needle is retracted. The supply of medication will
be stored in a sealed section of the body and be delivered
through the needle by means of a piston. Rapid delivery of the
medication will be achieved through the activation of a conical
shape memory alloy (SMA) compression spring. Activating
the spring by means of the Joules effect will remove the need
for a bulky complex trigger system to release the spring.
The needle positioning mechanism is capable of positioning
the needle at a number of points in a 360 degree envelope,
however for the purpose of prototyping 16 fixed positions
equally spaced have been chosen. The angular positioning
of the needle is achieved by the anticlockwise rotation of
the micro-motor while the advancement and retraction of the
needle is achieved by the clockwise rotation of the micro-
motor.
B. Positioning the Needle
Manoeuvring the needle to a selected position is achieved
by applying a negative voltage to the micro-motor. The
negative voltage will cause the micro-motor to rotate in an
anticlockwise direction. The needle funnel (Fig. 11a) rotates
anticlockwise by virtue of a ratchet which is mounted on the
micro-motor’s driveshaft. The ratchet engages with a set of
sprung legs which are integral to the needle funnel (Fig. 11b).
The needle is engaged with the needle funnel and is carried
round with it.
Fig. 11. Needle positioning mechanism: needle funnel a), ratchet driving
the needle funnel, which has material removed b) and the needle funnel arm
engaged with a protrusion c)
When the needle funnel is rotating anticlockwise an arm
which protrudes from the side of the needle funnel rides over
the top of a plurality of protrusions (Fig. 11c) on the inside
face of the body. The function of these protrusions is to prevent
the needle funnel from rotating clockwise when the motor is
reversed. It achieves this by engaging the end of the arms with
a parallel surface of the protrusion (Fig. 11c) preventing any
further movement clockwise and aligning the needle with one
of the 16 fixed ports on the micro-robot’s body.
C. Operating the Needle
Applying a positive voltage to the micro-motor reverses its
direction, this disengages the needle funnel ratchet from its
sprung legs and engages the needle cam ratchet with a set of
sprung legs that are integral to the needle cam (Fig. 12).
Fig. 12. 360 degree needle cam operating cycle: stored position a), full
stroke b), needle returning to the stored position c), and retracted position d)
When engaged the ratchet drives the needle cam in a
clockwise direction. The needle is engaged with a track in
the needle cam by means of a driving peg mounted on the
side of the needle (Fig. 12). The track is shaped to convert
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Fig. 13. 1:1 scale SLA prototypes. a) shows the needle cam, ratchet, spring
and needle combined with the driving peg b) shows the retaining cover and
c) is the needle funnel
the rotational motion of the cam into a variable linear motion.
This linear motion allows the advancement and retraction of
the needle.
Fig. 12 shows the sequence of operation for the extension
and retraction of the needle. Fig. 12a shows the needle in
the stored position, this is the position the needle will be in
when the micro-robot is swallowed and travels through the
GI tract to the target site. A compression spring is used to
ensure the driving peg maintains contact with the track and
also that the needle returns to the start position. Fig. 12b shows
the needle at full extension giving a reach of approximately
6.9 mm radius and a stroke length of 2.0 mm. The design of
the cam utilises a direct linear movement so that a positive
force can be delivered to the needle which will be required to
penetrate the wall of the GI tract. Fig. 12c shows the needle
retracting by virtue of the track slowly spiralling inwards and
the pressure exerted by the spring. Fig. 12d shows the needle
returning to the stored position once the medication has been
delivered. Further design analysis of the targeting mechanism
has been described in detail in previous work [17].
Fig. 13 shows the component parts of the needle positioning
mechanism. All the parts except the stainless steel spring
have been prototyped using a high resolution stereolithography
(SLA) manufacturing process. The one-to-one scaled proto-
types are manufactured from Accura 60 which is a resin with
similar mechanical properties to polycarbonate.
The assembled needle positioning components can be seen
in Fig. 14. Fig. 14a shows the needle funnel fitted with the
needle and spring. Fig. 14b shows the needle cam mounted
in the needle funnel and engaged with the needle’s drive peg.
Fig. 14c shows the ratchet mounted on a drive spindle and the
cavity in the case which will house the targeting mechanism.
Fig 14d shows the case fitted with the mechanism and the
drive spindle at the rear.
Fig. 14. Assembled needle positioning mechanism. a) shows the needle
funnel, spring and needle assembled b) shows the needle cam in position
c) shows the ratchet and case cavity and d) shows the case fitted with the
mechanism and coupled to a drive spindle
The proof of concept prototypes perform within the allow-
able design limits with all the arms flexing and returning
to their original positions. The spring allows the needle to
advance 2.0 mm and then return back to rest.
V. ADDITIONAL PLATFORM CONSIDERATIONS
In order to complete a system realisation of a targeted drug
delivery platform there are several aspects which, although
outside the scope of this paper, are necessary to realise. This
section will detail these considerations:
A. Localisation
It is an important requirement that the location of the micro-
robot is known when it passes through the GI tract [18]. The
spatial information will be used to determine where potential
pathologies have been located and hence give the ability to
return to these sites for follow-up treatment.
One method reported in the literature for following the
progress of a WCE through the GI tract is through the moni-
toring of the magnetic field strength of an on-board permanent
magnet [19]. Using a magnetic tracking algorithm and a
magnetoresistive sensor array attached to the skin the position
and orientation of the micro-robot can be estimated. Figures
reported by Wang et. al. (2006) [20] show average position
errors of 3.3 mm and average orientation errors of 3 degrees,
however the number of external sensors will determine the
overall accuracy of the system.
A widely used approach to localisation is through the
monitoring of electromagnetic waves [19]. Radio frequency
triangulation is employed on the M2A by Given Imaging.
This method utilises the received signal strength of the images
which are being transmitted to eight external receivers to
determine the position of the device. The average position error
of this method is 37.7 mm however this method is limited to
2D positioning [21].
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There are alternative methods to localisation such as gamma
scintigraphy. This method is employed on the InteliSite [7] by
Innovative Devices LLC. The capsule can be tracked through
the GI tract using gamma scintigraphy which will detect
Indium (111In) or Technetium (99mTc) gamma isotopes that
have been incorporated into the capsule. However the loca-
tional accuracy of the system is limited as capsule orientation
cannot be determined and only the capsule’s general position
within the GI tract can be ascertained.
It is intended that additional monitoring methods such as
recording pH levels and transit time will be combined with
a localisation method to give an overall indication of the
capsule’s location.
B. Electronics
It is crucially important to consider the various components
and wiring in such a space-constrained design. Key electronic
components include:
1) CMOS image sensor: This design uses a commercially-
available subminiature image sensor manufactured by Toshiba
(TCM8230MDA) with four white SMT LEDs manufactured
by Agilent (HSMW-C191) integrated on a PCB.
2) Rotary encoder and wiring: The micro-robot can be split
into four sections: the visualisation and processing section, the
needle positioning mechanism, the holding mechanism and the
power supply section. Fig. 15 highlights these sections with a
cut-through view of the micro-robot.
Fig. 15. Cut-through view of the micro-robot with the four main sections
labeled
The configuration of the four sections of the micro-robot
presents problems of power delivery, specifically delivering
power to the holding mechanism and the visualisation and
processing section. This is due to the requirement that the
holding mechanism can be deployed diametrically opposite the
needle, as this requires the front section of the micro-robot to
be able to rotate 360 degrees.
The solution is to run power lines on the outside of the
body from the power supply to a rotary encoder board, this
bypasses the need to disrupt the medication compartment. The
rotary encoder board has four concentric tracks equally spaced.
Contact pins held in the needle positioning mechanism can
contact the tracks yet still remain free to rotate. A fifth contact
pin is used in conjunction with a registration contact on the
rotary encoder board to determine the angular position of the
needle and holding mechanism.
3) Controller ASIC: The power management (i.e. DC/DC
conversion), telemetry, timing and control are being imple-
mented in a full-custom ASIC in a commercially-available
0.18µm CMOS technology. Much of the specific circuit
implementations will be based on previously reported systems
[22]–[24].
C. Energy Requirements
As the space available for the power supply onboard the
WCE is limited it is essential that the needle positioning
mechanism and the holding mechanism can both operate
with low power consumption. The energy requirements for
both mechanisms have been estimated from the peak cur-
rent consumption of the Namiki motor controller (SSD04)
and the Faulhaber motor controller (BLD05002S) which are
stated as 800 mA at 6 V and 400 mA at 7.5 V respectively.
Three revolutions of the Namiki micro-motor are required for
positioning and deployment of the needle; this is achieved
in 3.8 s while the holding mechanism can complete a full
opening and closing cycle in 1.78 s. Using a Lithium coin
battery with a volume of 188 mm3 and an energy density of
435 Wh/L (CR1025 Energizer) the mechanisms will consume
at most 28.94 J of energy for each complete cycle which is
only 9.8% of the available energy, offering the potential for
multiple operations.
VI. CONCLUSION
In this paper the authors have presented a novel targeted
drug delivery platform towards the realisation of a practical
micro-positioning system and holding mechanism for targeted
drug delivery in the small intestines. The platform can be
used for the detection and treatment of pathologies of the GI
tract such as Crohn’s disease, small intestinal tumours such as
lymphoma and small intestinal cancer.
It has been shown that the proposed needle positioning
mechanism and the holding mechanism achieve the required
functionality whilst occupying a combined volume of less than
470 mm3. This is based on the proposed needle positioning
mechanism and holding mechanism consuming a maximum
of 28.94 J of energy per operation.
The targeted drug delivery platform has the control nec-
essary to target a particular pathogen within the GI tract. It
is envisaged that a delivery mechanism capable of delivering
1 ml of medication to the target site can be incorporated
into the standard geometry of the WCE, with the combined
needle positioning system, holding mechanism and delivery
mechanism (including 1 ml of medication) occupying 60% of
the total available volume.
The research so far has been focused on the analysis of the
novel micro-positioning mechanism and the holding mecha-
nism. During in-vitro testing and validation these systems will
be tested to determine if the needle positioning mechanism
has sufficient power to penetrate the GI tract wall and that
the holding mechanism has sufficient power to overcome
peristalsis. An area for consideration is the miniaturisation of
the electronics and the development of a control system with
a user interface.
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